quantisnow
FeedTopReportsPricing
⌘K
Live feed
07:00:00·65d
PRRelease
Charles River Laboratories International Inc. logo

Charles River Laboratories Announces Fourth-Quarter and Full-Year 2025 Results and Provides 2026 Guidance

CRL· Charles River Laboratories International Inc.
Health Care
Original source

Companies

  • CRL
    Charles River Laboratories International Inc.
    Health Care

Recent analyst ratings

  • Apr 14UpdateRBC Capital Mkts$215.00
  • Dec 15UpdateBofA Securities$225.00
  • Nov 17UpdateArgus-
  • Nov 6UpdateRobert W. Baird$199.00
  • Oct 6UpdateWilliam Blair-
  • Oct 2UpdateBarclays$195.00

Related

  • PR3d
    Charles River Highlights Effectiveness of VCGs in Toxicology
  • PR8d
    Charles River Laboratories Schedules First-Quarter 2026 Earnings Release and Conference Call
  • ANALYST10d
    RBC Capital Mkts initiated coverage on Charles River with a new price target
  • PR14d
    Charles River Advances Cardiovascular Health Awareness Through Support of the American Heart Association
  • INSIDER15d
    SEC Form 3 filed by new insider Coleman Glenn
  • PR18d
    NYSE Content Update: Join Us and 6,500+ Attendees at Marquee AI Event HumanX
  • SEC24d
    SEC Form DEF 14A filed by Charles River Laboratories International Inc.
  • SEC28d
    Amendment: SEC Form SCHEDULE 13G/A filed by Charles River Laboratories International Inc.
quantisnow

Real-time market intelligence for retail investors. Press releases, filings, ratings, and insider flow - all in one stream.

All systems operational

Feeds

Press releasesAnalyst ratingsInsider tradingFDASECRSS feeds

Top lists

TrendingBy market capActive companiesAnalyst upgradesInsider purchasesFDA approvalsSEC filingsSectorsMarket reports

Company

AboutPricingPublish with usContact

Legal

Terms of usePrivacy policyCookie policy

© 2026 quantisnow.com · Democratizing insights since 2022